Search for pathway correlated target
You are searching for: hsa00240
T76285 Target Info |
Target Name | Phosphodiesterase I beta (ENPP3) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Renal cell carcinoma; | ||
Drugs | AGS-16C3F | Drug Info |
T58298 Target Info |
Target Name | Ectonucleoside triphosphate diphosphohydrolase 1 (CD39) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Lymphoma; Solid tumour/cancer; | ||
Drugs | IPH5201 | Drug Info |
T98089 Target Info |
Target Name | Deoxycytidine kinase (DCK) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | LP-661438 | Drug Info |
T15851 Target Info |
Target Name | Orotidine 5'-monophosphate decarboxylase (UMPS) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | Alpha-Phosphoribosylpyrophosphoric Acid | Drug Info |
T24548 Target Info |
Target Name | Aspartate carbamoyltransferase (CAD) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | N-(phosphonacetyl)-L-aspartate | Drug Info |
T42533 Target Info |
Target Name | Nucleoside diphosphate kinase A (NM23-H1) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | Not Available |
T22976 Target Info |
Target Name | Thymidine kinase 2 (Mt-TK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Thymidine kinase 2 deficiency; | ||
Drugs | MT-1621 | Drug Info |
T98397 Target Info |
Target Name | Thymidylate synthase (TYMS) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Gastric adenocarcinoma; Solid tumour/cancer; | ||
Drugs | Plevitrexed (R)-isomer | Drug Info |
T01249 Target Info |
Target Name | HUMAN dCTP pyrophosphatase 1 | |
---|---|---|---|
Target type | . Target | ||
Disease | Not Available | ||
Drugs | Not Available |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.